{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:56:13Z","timestamp":1791327373666,"version":"4.3.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.juro.2012.09.049","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T09:45:46Z","timestamp":1349689546000},"page":"711-718","source":"Crossref","is-referenced-by-count":55,"title":["Connaught and Russian Strains Showed the Highest Direct Antitumor Effects of Different Bacillus Calmette-Gu\u00e9rin Substrains"],"prefix":"10.1097","volume":"189","author":[{"given":"Silvia","family":"Secanella-Fandos","sequence":"first","affiliation":[{"name":"Departament de Gen\u00e8tica i de Microbiologia, Facultat de Bioci\u00e8ncies, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Luquin","sequence":"additional","affiliation":[{"name":"Departament de Gen\u00e8tica i de Microbiologia, Facultat de Bioci\u00e8ncies, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Juli\u00e1n","sequence":"additional","affiliation":[{"name":"Departament de Gen\u00e8tica i de Microbiologia, Facultat de Bioci\u00e8ncies, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.09.049_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.09.049_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2014different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.juro.2012.09.049_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tube.2008.12.001","article-title":"Phenotypic differences between BCG vaccines at the proteome level","volume":"89","author":"Rodriguez-Alvarez","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.juro.2012.09.049_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1574-695X.2009.00559.x","article-title":"Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) substrains","volume":"56","author":"Hayashi","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.juro.2012.09.049_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1574-6968.2010.01947.x","article-title":"Biochemical characteristics among Mycobacterium bovis BCG substrains","volume":"306","author":"Hayashi","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.juro.2012.09.049_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4161\/hv.5.2.7210","article-title":"BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy","volume":"5","author":"Liu","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.juro.2012.09.049_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/499825","article-title":"The effect of bacille Calmette-Gu\u00e9rin vaccine strain and route of administration on induced immune responses in vaccinated infants","volume":"193","author":"Davids","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.juro.2012.09.049_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.vaccine.2008.10.058","article-title":"Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strain of disparate genealogy induce comparable protective immunity against tuberculosis","volume":"27","author":"Horwitz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.juro.2012.09.049_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1475-2867-10-21","article-title":"BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis","volume":"10","author":"Schwarzer","year":"2010","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.juro.2012.09.049_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10482-006-9062-1","article-title":"The production of a new extracellular putative long-chain saturated polyester by smooth variants of Mycobacterium vaccae interferes with Th1-cytokine production","volume":"90","author":"Rodr\u00edguez-G\u00fcell","year":"2006","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.juro.2012.09.049_bib11","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1128\/JB.01485-09","article-title":"Microscopic cords, a virulence-related characteristic of Mycobacterium tuberculosis, are also present in nonpathogenic mycobacteria","volume":"192","author":"Juli\u00e1n","year":"2010","journal-title":"J Bacteriol"},{"key":"10.1016\/j.juro.2012.09.049_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00299720","article-title":"Cytostatic effect of different strains of Bacillus Calmette-Gu\u00e9rin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alpha","volume":"20","author":"Rajala","year":"1992","journal-title":"Urol Res"},{"key":"10.1016\/j.juro.2012.09.049_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<851::AID-IJC25>3.0.CO;2-9","article-title":"Effects of bacillus Calmette-Guerin and interferon-alpha-2B on human bladder cancer in vitro","volume":"71","author":"Zhang","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2012.09.049_bib14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1464-410X.2006.06026.x","article-title":"Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Gu\u00e9rin through Toll-like receptor signalling","volume":"97","author":"Miyazaki","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.09.049_bib15","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00432-011-1056-3","article-title":"BCG response prediction with cytokine gene variants and bladder cancer: where we are?","volume":"137","author":"Ahirwar","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.juro.2012.09.049_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00941903","article-title":"Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer","volume":"25","author":"de Boer","year":"1997","journal-title":"Urol Res"},{"key":"10.1016\/j.juro.2012.09.049_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1442-2042.2007.01696.x","article-title":"Intravesical instillation therapy with bacillus Calmette-Gu\u00e9rin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"14","author":"Shintani","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.juro.2012.09.049_bib18","first-page":"8051","article-title":"Interleukin-6\u2013174G\u00e0C polymorphism is associated with improved outcome in high-risk breast cancer","volume":"63","author":"DeMichele","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2012.09.049_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2012.09.049_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0022-5347(01)67113-1","article-title":"Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy","volume":"154","author":"Esuvaranathan","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.09.049_bib21","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0022-5347(05)67678-1","article-title":"Autocrine IL-6 production by human transitional carcinoma cells upregulates expression of the alpha5beta1 fibronectin receptor","volume":"163","author":"Zhang","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.09.049_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00296835","article-title":"Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG)","volume":"21","author":"de Reijke","year":"1993","journal-title":"Urol Res"},{"key":"10.1016\/j.juro.2012.09.049_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00184116","article-title":"Specific binding of bacillus Calmette-Gu\u00e9rin to urothelial tumor cells in vitro","volume":"12","author":"Schneider","year":"1994","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2012.09.049_bib24","first-page":"1315","article-title":"Internalization of Mycobacterium bovis, Bacillus Calmette Guerin, by bladder cancer cells is cytotoxic","volume":"18","author":"Pook","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.juro.2012.09.049_bib25","first-page":"181","article-title":"BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated bladder cancer cell lines","volume":"9","author":"Bevers","year":"1998","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.juro.2012.09.049_bib26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1097-0215(20000915)87:6<844::AID-IJC14>3.0.CO;2-5","article-title":"What are the immunologically active components of bacille Calmette-Gu\u00e9rin in therapy of superficial bladder cancer?","volume":"87","author":"Zlotta","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2012.09.049_bib27","doi-asserted-by":"crossref","first-page":"e1000081","DOI":"10.1371\/journal.ppat.1000081","article-title":"Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production","volume":"4","author":"Dao","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.juro.2012.09.049_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature02837","article-title":"A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response","volume":"431","author":"Reed","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.juro.2012.09.049_bib29","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.09.049_bib30","doi-asserted-by":"crossref","unstructured":"Birkh\u00e4user F, Rentsch CA, Studer UE et al: The BCG strain used is relevant for recurrence-free survival: a randomized phase III study comparing Immucyst\u00ae versus Oncotice\u00ae. Presented at annual congress of European Association of Urology, Paris, France, February 24\u201328, 2012, abstract 962.","DOI":"10.1016\/S1569-9056(12)60959-2"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471204880X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471204880X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.09.049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:02:12Z","timestamp":1651201332000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.09.049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1016\/j.juro.2012.09.049"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.09.049","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}